Vivani Medical
VANI
21 hedge funds and large institutions have $865K invested in Vivani Medical in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 13 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
1.61% more ownership
Funds ownership: 0.24% → 1.85% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
30% less funds holding
Funds holding: 30 → 21 (-9)
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
84% less capital invested
Capital invested by funds: $5.32M → $865K (-$4.46M)
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$228K |
| 2 |
Morgan Stanley
New York
|
+$45.5K |
| 3 |
WA
WealthTrust Axiom
Wayne,
Pennsylvania
|
+$35.3K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$15.6K |
| 5 |
BlackRock
New York
|
+$15.1K |
Top Sellers
VANI Hedge Fund Activity: Q1 2020 in Review
21 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q1 2020, worth a combined $865K — down 84% from $5.32M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of VANI and 6 opened new positions — a net loss of 7 holders — while 4 trimmed existing stakes and 7 added.
The largest buyer was Susquehanna International Group, adding an estimated $228K. The largest seller was Sigma Planning Corp, exiting entirely with an estimated $281K sold.
- 21 institutional investors held Vivani Medical (VANI) as of Q1 2020, down from 30 in Q4 2019.
- Funds reported $865K of Vivani Medical stock for Q1 2020, down 84% quarter-over-quarter.
- 6 funds opened new Vivani Medical positions in Q1 2020 and 13 closed out, a net change of -7 holders.
- The largest Vivani Medical buyer in Q1 2020 was Susquehanna International Group, an estimated $228K added.
- The largest Vivani Medical seller in Q1 2020 was Sigma Planning Corp, an estimated $281K sold.
Based on aggregated 13F filings for Q1 2020.